Answers are grounded in this paper and cite their sources.
Biofilm-induced bacterial infections are refractory to conventional antibiotics and easily cause persistent tissue damage, severely threatening human health. Copper-initiated cuproptosis-like death serves as an antibacterial pathway, yet simple copper supplementation fails to achieve satisfactory bactericidal effects due to bacterial copper homeostasis and physiological copper chelation. Copper ionophore elesclomol (ES) can selectively deliver intracellular copper to trigger cuproptosis, while photothermal therapy (PTT) is a promising antibacterial strategy with a low drug resistance risk. Herein, a Janus mesoporous ES-loaded nanoparticle (CSP@ES NPs) was fabricated to integrate cuproptosis-like death and PTT for therapy. In the acidic biofilm microenvironment, CSP@ES degrades sustainably to release Cu and ES, which disrupts bacterial copper homeostasis, downregulates dihydrolipoamide S-acetyltransferase (DLAT)/FDX1 expression, and may trigger responses compatible with cuproptosis-like bacterial death. Combined with PTT, CSP@ES achieves prominent in vitro antibiofilm and in vivo antibacterial effects with favorable biosafety. This work provides a feasible multimodal therapeutic strategy for refractory bacterial infections with great clinical translation potential.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: